Literature DB >> 15936508

Expression of Ki67, PCNA and the chromosome replication licensing protein Mcm2 in glial cells of the ageing human hippocampus increases with the burden of Alzheimer-type pathology.

Stephen B Wharton1, Gareth H Williams, Kai Stoeber, Catherine H Gelsthorpe, Lynne Baxter, Anthony L Johnson, Paul G Ince.   

Abstract

Cell-cycle mechanisms may be aberrantly reactivated in the ageing brain and associated with the development of pathology, including Alzheimer's disease. Activation of cell-cycle mechanisms in glia has, however, been little studied. Our aim was to determine whether expression of a marker for chromosomal replication licensing, Mcm2, occurs in glia of the ageing hippocampus, and to compare its expression to that of Ki67 and PCNA. Blocks of hippocampus were obtained from 19 elderly brains derived from the MRC-CFAS neuropathology cohort, which included a spectrum of Alzheimer-type pathology, semi-quantified using the Braak scoring system for neurofibrillary tangles. Mcm2, PCNA and Ki67 were detected immunohistochemically. Expression of Mcm2, Ki67 and PCNA was observed in glial cells and neurons, with a trend to increased expression in association with higher burdens of Alzheimer-type pathology. Mcm2 expression in glial cells showed a significant linear trend across Braak stages (P = 0.043). This study demonstrates that grey and white matter glial cells show expression of cell-cycle markers in the ageing brain and that re-licensing for chromosomal replication is a component of the mechanisms activated. A quantitative relationship to the burden of Alzheimer-type pathology suggests that cell-cycle re-entry in glial cells may be important in the pathogenesis of age-related neurodegeneration.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15936508     DOI: 10.1016/j.neulet.2005.04.019

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  13 in total

1.  Neurogenesis in Alzheimer´s disease: a realistic alternative to neuronal degeneration?

Authors:  Rocío E Gonzalez-Castaneda; Alma Y Galvez-Contreras; Sonia Luquín; Oscar Gonzalez-Perez
Journal:  Curr Signal Transduct Ther       Date:  2011-09-01

2.  The effects of chronic alcoholism on cell proliferation in the human brain.

Authors:  G T Sutherland; P J Sheahan; J Matthews; C V P Dennis; D S Sheedy; T McCrossin; M A Curtis; J J Kril
Journal:  Exp Neurol       Date:  2013-03-28       Impact factor: 5.330

3.  Determination of key aspects of precursor cell proliferation, cell cycle length and kinetics in the adult mouse subgranular zone.

Authors:  C D Mandyam; G C Harburg; A J Eisch
Journal:  Neuroscience       Date:  2007-02-20       Impact factor: 3.590

Review 4.  Neurogenesis in aging and age-related neurodegenerative diseases.

Authors:  Luka Culig; Xixia Chu; Vilhelm A Bohr
Journal:  Ageing Res Rev       Date:  2022-04-29       Impact factor: 11.788

Review 5.  Phospholipase A2 activation as a therapeutic approach for cognitive enhancement in early-stage Alzheimer disease.

Authors:  Evelin L Schaeffer; Orestes V Forlenza; Wagner F Gattaz
Journal:  Psychopharmacology (Berl)       Date:  2008-10-14       Impact factor: 4.530

6.  A phenotypic change but not proliferation underlies glial responses in Alzheimer disease.

Authors:  Alberto Serrano-Pozo; Teresa Gómez-Isla; John H Growdon; Matthew P Frosch; Bradley T Hyman
Journal:  Am J Pathol       Date:  2013-04-18       Impact factor: 4.307

Review 7.  Multifunctional drug treatment in neurotrauma.

Authors:  Bogdan Stoica; Kimberly Byrnes; Alan I Faden
Journal:  Neurotherapeutics       Date:  2009-01       Impact factor: 7.620

8.  Ranking candidate disease genes from gene expression and protein interaction: a Katz-centrality based approach.

Authors:  Jing Zhao; Ting-Hong Yang; Yongxu Huang; Petter Holme
Journal:  PLoS One       Date:  2011-09-02       Impact factor: 3.240

9.  Proliferation in the Alzheimer hippocampus is due to microglia, not astroglia, and occurs at sites of amyloid deposition.

Authors:  Michael W Marlatt; Jan Bauer; Eleonora Aronica; Elise S van Haastert; Jeroen J M Hoozemans; Marian Joels; Paul J Lucassen
Journal:  Neural Plast       Date:  2014-08-19       Impact factor: 3.599

10.  Protective effects of 1α,25-Dihydroxyvitamin D3 on cultured neural cells exposed to catalytic iron.

Authors:  Francesca Uberti; Vera Morsanuto; Claudio Bardelli; Claudio Molinari
Journal:  Physiol Rep       Date:  2016-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.